How drug companies turned “depression” into a billion-dollar industry
Once upon a time, anxiety was anxiety. Maybe you were going for a root canal, taking a flight when you were a nervous flier, or meeting your in-laws for the first time, so you had “nerves.”
That was then. Sensing an untapped market, drugmakers who funded writers of the Diagnostic and Statistical Manual of Mental Disorders or “DSM” (the Bible for mental conditions) recast anxiety as “really depression,” and suddenly everyone …